Subsequently, modulation of GFAPα and the GFAPδ/α ratio in an astrocytoma cell model resulted in transcriptional changes, which we related to the observations in patients, and resulted in the identification of a set of high-malignant and low-malignant genes that are regulated by GFAP. The gene discussed is GFAP; the disease is astrocytoma (excluding glioblastoma).